HF
PRQR icon

HRT Financial’s ProQR Therapeutics PRQR Stock Holding History

HRT Financial’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,297
Closed -$25K – 3490
2025
Q2 		$25K Buy
+12,297
New +$20K ﹤0.01% 2378
2023
Q3 		– Sell
-21,494
Closed -$34K – 2944
2023
Q2 		$34K Sell
21,494
-149,812
-87% -$293K ﹤0.01% 2053
2023
Q1 		$364K Buy
+171,306
New +$524K ﹤0.01% 1595
2022
Q3 		– Sell
-46,469
Closed -$36K – 3341
2022
Q2 		$36K Buy
+46,469
New +$34.6K ﹤0.01% 2543
2020
Q1 		– Sell
-56,682
Closed -$561K – 1225
2019
Q4 		$561K Buy
+56,682
New +$441K 0.02% 493

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

HRT Financial's PRQR Position: Q3 2025 in Review

HRT Financial sold out of ProQR Therapeutics (PRQR) in Q3 2025, closing a stake of 12,297 shares — an estimated $25K sold.

HRT Financial first reported a position in PRQR in Q4 2019 and held it in 5 quarters. The position peaked at $561K in Q4 2019. 64 funds tracked by Wall St. Rank hold PRQR as of Q3 2025.

  • HRT Financial reported no remaining ProQR Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 12,297 ProQR Therapeutics shares in Q3 2025, an estimated $25K.
  • HRT Financial first reported a position in ProQR Therapeutics in Q4 2019 and held it in 5 quarters.
  • HRT Financial's ProQR Therapeutics position peaked at $561K in Q4 2019.
  • 64 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.